Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 1/10/2013 12:36:54 PM : Outperform Start Price: $45.15 SLXP Score: +4.75

optomistic with FDA approval

Featured Broker Partners


Advertisement